Atossa Therapeutics, Inc. (ATOS)

4.21 -0.21 (-4.75%) USD  |  NASDAQ  |  Feb 20, 16:00
4.14 -0.07 (-1.66%) After-Hours: 20:00
More

Atossa Therapeutics Outperform Recommendations

Outperform Recommendations Chart

View Outperform Recommendations for ATOS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Outperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Outperform Recommendations Range, Past 5 Years

View Outperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Outperform Recommendations Benchmarks

View Outperform Recommendations Benchmarks
Start Trial
Celldex Therapeutics, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Abeona Therapeutics, Inc. Upgrade
Cell Source, Inc. --
Kiora Pharmaceuticals, Inc. Upgrade